marketboard
← Back to board

MRNA · MRNA

US Stocks

Current price

$0.00

0.0% today

Bearish

42

+0 vs yesterday

Reasoning

Last updated: 8 hr ago

Risk: medium
covid-vaccinedebt-offeringpipeline-upgrade

Moderna faces near-term pressure from a dilutive $2.6B debt offering despite FDA approval of updated COVID-19 vaccines, resulting in a slight bearish lean.

Sources considered

NewsReliability: Medium · 60%

dailypolitical.com

Moderna, Revolution Medicines, and Amgen are the three Biotech stocks to watch today, according to MarketBeat’s stock screener tool. Biotech stocks are shares of publicly traded companies that develop

Open source ↗
NewsReliability: Medium · 60%

stocktitan.net

HELIOS-B included 654 patients, 259 receiving tafamidis at baseline; Alnylam also reported greater blood-pressure reductions with zilebesiran in a subgroup.

Open source ↗
NewsReliability: Medium · 60%

finance.yahoo.com

Moderna, Inc. (NASDAQ:MRNA) proposed a private placement of $2.0 billion in convertible senior notes due in 2032, with an option for initial purchasers to acquire another $300 million. The notes would

Open source ↗
NewsReliability: Medium · 60%

philstockworld.com

NEW YORK (AP) — The bond market swung Friday as investors built bets that the Federal Reserve may hike interest rates soon to get the nation’s high inflation under control. U.S. stocks, meanwhile…

Open source ↗
NewsReliability: Medium · 60%

seekingalpha.com

The major indices were higher last week but masked a weaker performance. Click here to read more about the market.

Open source ↗
NewsReliability: Medium · 60%

orlandosentinel.com

A dreamy morning can still lead to something useful. The Moon conjoins Neptune at 5:19 am EDT, softening the mood and bringing imagination, empathy, and intuition closer to the surface. Details may fe

Open source ↗